X @Bloomberg
Sarepta Therapeutics(US:SRPT) Bloombergยท2025-07-25 10:52Sarepta shares drop 14% in premarket trading after its gene therapy fails to get EU regulator approval https://t.co/4inyYyirFu ...
Sarepta Therapeutics(US:SRPT) Bloombergยท2025-07-25 10:52